Idiopathic thrombocytopenic purpura and the second dose of MMR [6]

Archives of Disease in Childhood

Volumn 93, Issue 2, 2008, Pages 182-183

  Stowe, Julia ^a   Kafatos, George ^a   Andrews, Nick ^a   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

CHILD HEALTH CARE; COMPUTER PROGRAM; DISEASE PREDISPOSITION; DOSE RESPONSE; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; LETTER; MEDICAL RECORD; PATIENT SATISFACTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; VALIDATION STUDY; CHILD; HOSPITALIZATION; IMMUNIZATION; PRESCHOOL CHILD; STATISTICS;

CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; MEASLES-MUMPS-RUBELLA VACCINE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK ASSESSMENT;

EID: 38849187326     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.126003     Document Type: Letter

References (6)

1. Miller E, Waight P, Farrington P, et al. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001;84(3):227-9.
2. Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Brit J Clin Pharmacol 2003;55:107-11.
3. Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/ rubella vaccines. Lancet 1995;345:567-9.
4. Vlacha V, Forman EN, Miron D, et al. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination. Pediatrics 1996;97:738-9.
5. Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. N Engl J Med 1966;275:352-6.
6. Joint Committee on Vaccine and Immunisation. Immunisation against infectious disease. Salisbury, D, Ramsay, M, Noakes, K, eds. DOH.London: Stationery Office, 2006.